6 different filers disclosed BSX within 90 days. Disclosed 22 days after the transaction; reported as an official range, not an exact amount.
Traded Oct 28, 2025 · Filed Oct 28, 2025
A board member of Boston Scientific sold $297K of Boston Scientific shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$296,599
Shares × reported transaction price
6 days after results of Oct 22, 2025, 99 days before results of Feb 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $100.97 on Oct 28, 2025, 21% above its 52-week low and 7% below its high, after a 2% rise over the previous 30 trading days
52-week range $83.62 (Nov 1, 2024) to $108.14 (Sep 8, 2025), 71% of the way up, from 250 adjusted closes. 30 trading days earlier: $98.98 on Sep 16, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -1.4% | -1.4% | +0.0% |
| 30 days | +1.3% | -0.6% | +1.9% |
| 90 days | -6.7% | +1.2% | -7.8% |
| 180 days | -40.2% | +4.0% | -44.3% |
Past results only. Not a forecast.
6 different filers disclosed BSX within 90 days. Disclosed 22 days after the transaction; reported as an official range, not an exact amount.
6 different filers disclosed BSX within 90 days. Disclosed 22 days after the transaction; reported as an official range, not an exact amount.
6 different filers disclosed BSX within 90 days. Disclosed 21 days after the transaction; reported as an official range, not an exact amount.